A study to evaluate the safety, tolerability and efficacy of the addition of a new drug (MK-3102) in patients with Type 2 Diabetes who are already taking Metformin (licensed drug)

Update Il y a 5 ans
Reference: EUCTR2012-003670-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- After 24 weeks, to assess the effect of the addition of treatment with MK- 3102 compared to placebo on A1C. - To assess the safety and tolerability of MK-3102.


Inclusion criteria

  • Type 2 diabetes mellitus